Offer - Urjas Oil for just ₹ 1 X
Thyroweek 25 Tablet is a commercial drug that is prescribed in the form of Tablet. Hypothyroidism are some of its major therapeutic uses. Other than this, Thyroweek 25 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Thyroweek 25 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Some other side effects of Thyroweek 25 Tablet have been listed ahead. Normally, these side effects of Thyroweek 25 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Thyroweek 25 Tablet's effect during pregnancy is Safe and Mild while nursing. Warnings related to Thyroweek 25 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Thyroweek 25 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Hypopituitarism are examples of such conditions. Other conditions have been mentioned below in the Thyroweek 25 Tablet contraindications section.
Drug reaction of Thyroweek 25 Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Thyroweek 25 Tablet is safe while driving, and is is addictive in nature.
Thyroweek 25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Thyroweek 25 Tablet safe for pregnant women?
There are no side effects of Thyroweek in pregnant women.
Is the use of Thyroweek 25 Tablet safe during breastfeeding?
Breastfeeding women can take Thyroweek as it bears very minor side effects for them.
What is the effect of Thyroweek 25 Tablet on the Kidneys?
Thyroweek is not harmful for kidneys.
What is the effect of Thyroweek 25 Tablet on the Liver?
Using Thyroweek does not have any harmful effects on the liver.
What is the effect of Thyroweek 25 Tablet on the Heart?
There are no any side effects of Thyroweek for the heart.
Thyroweek 25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Thyroweek 25 Tablet unless your doctor advises you to do so -
Is this Thyroweek 25 Tablet habit forming or addictive?
No, there is no any evidence that Thyroweek 25 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Thyroweek 25 Tablet does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Thyroweek 25 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Thyroweek 25 Tablet in mental disorders is not effective.
Interaction between Food and Thyroweek 25 Tablet
It is safe to take Thyroweek 25 Tablet with food.
Interaction between Alcohol and Thyroweek 25 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Thyroweek 25 Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levoxyl (levothyroxine sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 769-770